Trenton — New Jersey CannaBusiness Association (NJCBA) President Edmund DeVeaux issued the following statement today regarding passage of the federal Medical Marijuana and Cannabidiol Research Expansion Act, which expands research into cannabis-derived medications:
“Each day brings more positive developments in the cannabis cause. Expanding and actually encouraging research into cannabis-derived medications is a commonsense measure that will better the lives of countless individuals. Moreover, it is a great step forward in the continued normalization of the growth and usage of cannabis.
“Hopefully this is a sign of more positive developments to come, including passage of the SAFE Banking Act and removing cannabis as a Schedule 1 substance. In the meantime, we look forward to President Biden signing this legislation.”